Literature DB >> 8395336

Clonal analysis of fibroadenoma and phyllodes tumor of the breast.

S Noguchi1, K Motomura, H Inaji, S Imaoka, H Koyama.   

Abstract

Clonality of fibroadenoma and phyllodes tumor of the breast was analyzed by means of the polymerase chain reaction using small DNA samples prepared from cryostat sections. The method of clonal analysis was based on restriction fragment length polymorphism of X-chromosome-linked phosphoglycerokinase gene and on differential methylation of the gene. Specimens from 10 fibroadenomas and 5 phyllodes tumors heterozygous for the BstXI polymorphism of PGK gene were subjected to clonal analysis. It was found that fibroadenoma was polyclonal, but phyllodes tumor was made up of both monoclonal and polyclonal cell components. Since these tumors contained both epithelial and stromal components, clonality of each component was analyzed separately. Analysis of clonality of each cell component showed that both the epithelial and stromal cells were polyclonal in fibroadenoma and that the epithelial cells were polyclonal, but the stromal cells were monoclonal in phyllodes tumor. When DNA samples were prepared from widely separated sites of phyllodes tumors, every sample was found to contain a monoclonal stromal cell component. These results demonstrate that fibroadenoma is a hyperplastic lesion rather than a neoplasm, and that phyllodes tumor is a neoplasm of the stromal cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395336

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

Review 1.  The clonal origin and clonal evolution of epithelial tumours.

Authors:  S B Garcia; M Novelli; N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

2.  Phyllodes Tumor of the Breast: Pathology, Histogenesis, Diagnosis, and Treatment.

Authors: 
Journal:  Breast Cancer       Date:  1996-06-28       Impact factor: 4.239

3.  Expression of acidic fibroblast growth factor (aFGF) and fibroblast growth factor receptor 4 (FGFR4) in breast fibroadenomas.

Authors:  S La Rosa; F Sessa; L Colombo; M G Tibiletti; D Furlan; C Capella
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

4.  Preoperative Discrimination of Fibroadenoma Which Is Clinically and Cytologically Indistinguishable from Breast Carcinoma through Clonal Analysis of Fine Needle Aspirate of Tumor: Report of a Case.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

5.  Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.

Authors:  Benjamin Yongcheng Tan; Nur Diyana Md Nasir; Huan Ying Chang; Cedric Chuan Young Ng; Peiyong Guan; Sanjanaa Nagarajan; Vikneswari Rajasegaran; Jing Yi Lee; Jing Quan Lim; Aye Aye Thike; Bin Tean Teh; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2020-04-22       Impact factor: 7.842

6.  Molecular analysis of phyllodes tumors reveals distinct changes in the epithelial and stromal components.

Authors:  E J Sawyer; A M Hanby; P Ellis; S R Lakhani; I O Ellis; S Boyle; I P Tomlinson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

7.  A rapidly progressive giant tumor with one year growth on breast: a rare size breast mass.

Authors:  Jian-Ping Liu; Gui-E Lai; Feng-En Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

8.  A Clinicopathological Study of Benign Phyllodes Tumour of Breast with Emphasis on Unusual Features.

Authors:  Kishori Moni Panda; Reena Naik
Journal:  J Clin Diagn Res       Date:  2016-07-01

9.  Molecular pathogenesis of progression and recurrence in breast phyllodes tumors.

Authors:  Ana Richelia Jara-Lazaro; Puay Hoon Tan
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

10.  Expression of TWIST1, Snail, Slug, and NF-κB and methylation of the TWIST1 promoter in mammary phyllodes tumor.

Authors:  Sung-Im Do; Ji Yeon Kim; So Young Kang; Jae Joon Lee; Jeong Eon Lee; Seok Jin Nam; Eun Yoon Cho
Journal:  Tumour Biol       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.